Skip to main content
main-content

Zeitschrift

Breast Cancer Research and Treatment

Breast Cancer Research and Treatment 3/2018

Ausgabe 3/2018

Inhaltsverzeichnis ( 26 Artikel )

07.02.2018 | Review | Ausgabe 3/2018

Targeting the PI3K/AKT/mTOR pathway in triple-negative breast cancer: a review

Ricardo L. B. Costa, Hyo Sook Han, William J. Gradishar

08.02.2018 | Review | Ausgabe 3/2018

First international TNBC conference meeting report

Padmashree Rida, Angela Ogden, Ian O. Ellis, Zsuzsanna Varga, Antonio C. Wolff, Tiffany A. Traina, Christos Hatzis, Julie R. Palmer, Christine B. Ambrosone, Brian D. Lehmann, Rita Nanda, Valerie Montgomery Rice, Otis W. Brawley, Mylin A. Torres, Emad Rakha, Ritu Aneja

08.02.2018 | Review | Ausgabe 3/2018

Influence of control group therapy on the benefit from dose-dense chemotherapy in early breast cancer: a systemic review and meta-analysis

Hadar Goldvaser, Habeeb Majeed, Domen Ribnikar, Boštjan Šeruga, Alberto Ocaña, David W. Cescon, Eitan Amir

06.02.2018 | Preclinical study | Ausgabe 3/2018

Cell growth inhibition and apoptosis in breast cancer cells induced by anti-FZD7 scFvs: involvement of bioinformatics-based design of novel epitopes

Neda Zarei, Mehdi Fazeli, Mozafar Mohammadi, Foroogh Nejatollahi

08.02.2018 | Preclinical study | Ausgabe 3/2018

Impact of physiological hormonal fluctuations on 18F-fluorodeoxyglucose uptake in breast cancer

Kanae K. Miyake, Yuji Nakamoto, Shigehira Saji, Tomoharu Sugie, Kensuke Kurihara, Shotaro Kanao, Debra M. Ikeda, Masakazu Toi, Kaori Togashi

17.02.2018 | Preclinical study | Ausgabe 3/2018

Prostate-specific membrane antigen in breast cancer: a comprehensive evaluation of expression and a case report of radionuclide therapy

Yuri Tolkach, Heidrun Gevensleben, Ralph Bundschuh, Aydan Koyun, Daniela Huber, Christina Kehrer, Thomas Hecking, Mignon-Denise Keyver-Paik, Christina Kaiser, Hojjat Ahmadzadehfar, Markus Essler, Walther Kuhn, Glen Kristiansen

20.02.2018 | Preclinical study | Ausgabe 3/2018

A hedgehog pathway-dependent gene signature is associated with poor clinical outcomes in Luminal A breast cancer

M. Rudolph, S. T. Sizemore, Y. Lu, K. Y. Teng, M. M. Basree, R. Reinbolt, C. D. Timmers, G. Leone, M. C. Ostrowski, S. Majumder, B. Ramaswamy

05.02.2018 | Clinical trial | Ausgabe 3/2018

First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial

Wolfgang Janni, Emilio Alba, Thomas Bachelot, Sami Diab, Miguel Gil-Gil, Thaddeus J. Beck, Larisa Ryvo, Rafael Lopez, Michaela Tsai, Francisco J. Esteva, Pilar Zamora Auñón, Zdenek Kral, Patrick Ward, Paul Richards, Timothy J. Pluard, Santosh Sutradhar, Michelle Miller, Mario Campone

10.02.2018 | Clinical trial | Ausgabe 3/2018

Breast cancer subtype and survival by parity and time since last birth

H. De Mulder, A. Laenen, H. Wildiers, K. Punie, A. Poppe, C. Remmerie, H. Lefrère, I. Nevelsteen, A. Smeets, E. Van Nieuwenhuysen, S. Han, E. Van Limbergen, G. Floris, I. Vergote, P. Neven

10.02.2018 | Clinical trial | Ausgabe 3/2018

Performance of breast cancer screening using digital breast tomosynthesis: results from the prospective population-based Oslo Tomosynthesis Screening Trial

Per Skaane, Sofie Sebuødegård, Andriy I. Bandos, David Gur, Bjørn Helge Østerås, Randi Gullien, Solveig Hofvind

12.02.2018 | Clinical trial | Ausgabe 3/2018

Do patients whose tumor achieved a pathological response relapse at specific sites? A substudy of the EORTC 10994/BIG-1-00 trial

Kim C. Aalders, Nathan Touati, Konstantinos Tryfonidis, Mylène Annonay, Saskia Litiere, Jonas Bergh, Alexandre Bodmer, David A. Cameron, Hervé R. Bonnefoi, on behalf of the EORTC 10994/BIG 1-00 Study Investigators

12.02.2018 | Clinical trial | Ausgabe 3/2018

Chest wall recurrence in pT1-2N0-1 breast cancer patients after mastectomy without radiotherapy

Ji Hyun Chang, Kyung Hwan Shin, Seung Do Ahn, Hae Jin Park, Eui Kyu Chie, Jin Ho Kim, Su Ssan Kim, Yong Bae Kim, Won Park, Yeon-Joo Kim, Hyun Soo Shin, Jin Hee Kim, Sun Young Lee, Kyubo Kim, Kyung Ran Park, Bae Kwon Jeong, Ja Young Kim, Suzy Kim

13.02.2018 | Clinical trial | Ausgabe 3/2018 Open Access

The clinical impact of molecular breast imaging in women with proven invasive breast cancer scheduled for breast-conserving surgery

Angela Collarino, Renato A. Valdés Olmos, Lotta G. A. J. van Berkel, Peter A. Neijenhuis, Lidy M. H. Wijers, Frederik Smit, Lioe-Fee de Geus-Oei, Lenka M. Pereira Arias-Bouda

13.02.2018 | Clinical trial | Ausgabe 3/2018

Evaluation of [89Zr]trastuzumab-PET/CT in differentiating HER2-positive from HER2-negative breast cancer

Farrokh Dehdashti, Ningying Wu, Ron Bose, Michael J. Naughton, Cynthia X. Ma, Bernadette V. Marquez-Nostra, Philipp Diebolder, Cedric Mpoy, Buck E. Rogers, Suzanne E. Lapi, Richard Laforest, Barry A. Siegel

16.02.2018 | Clinical trial | Ausgabe 3/2018 Open Access

Safety and feasibility of breast lesion localization using magnetic seeds (Magseed): a multi-centre, open-label cohort study

James R. Harvey, Yit Lim, John Murphy, Miles Howe, Julie Morris, Amit Goyal, Anthony J. Maxwell

17.02.2018 | Clinical trial | Ausgabe 3/2018

Patient-reported predictors of early treatment discontinuation: treatment-related symptoms and health-related quality of life among postmenopausal women with primary breast cancer randomized to anastrozole or exemestane on NCIC Clinical Trials Group (CCTG) MA.27 (E1Z03)

Lynne I. Wagner, Fengmin Zhao, Paul E. Goss, Judith-Anne W. Chapman, Lois E. Shepherd, Timothy J. Whelan, Bassam I. Mattar, Jose A. Bufill, William C. Schultz, Irving E. LaFrancis, Gauri G. Nagargoje, Radhakrishna Vemuri, Daniel A. Nikcevich, George W. Sledge, David Cella

19.02.2018 | Clinical trial | Ausgabe 3/2018 Open Access

Acute toxicity of intraoperative radiotherapy and external beam-accelerated partial breast irradiation in elderly breast cancer patients

D. H. M. Jacobs, G. Speijer, A. L. Petoukhova, E. M. A. Roeloffzen, M. Straver, A. Marinelli, U. Fisscher, A. G. Zwanenburg, J. Merkus, C. A. M. Marijnen, M. E. Mast, P. C. M. Koper

05.02.2018 | Epidemiology | Ausgabe 3/2018

Physical activity during adolescence and young adulthood and the risk of breast cancer in BRCA1 and BRCA2 mutation carriers

Jacqueline Lammert, Jan Lubinski, Jacek Gronwald, Tomasz Huzarski, Susan Armel, Andrea Eisen, Wendy S. Meschino, Henry T. Lynch, Carrie Snyder, Charis Eng, Olufunmilayo I. Olopade, Ophira Ginsburg, William D. Foulkes, Christine Elser, Stephanie A. Cohen, Marion Kiechle, Steven A. Narod, Joanne Kotsopoulos

08.02.2018 | Epidemiology | Ausgabe 3/2018

Association between financial burden and adjuvant hormonal therapy adherence and persistent use for privately insured women aged 18–64 years in BCBS of Texas

Junghyun Kim, Suja S. Rajan, Xianglin L. Du, Luisa Franzini, Sharon H. Giordano, Robert O. Morgan

14.02.2018 | Epidemiology | Ausgabe 3/2018

A comparison of two models for breast cancer mortality for women with ductal carcinoma in situ: an SEER-based analysis

Vasily Giannakeas, Victoria Sopik, Steven A. Narod

14.02.2018 | Epidemiology | Ausgabe 3/2018

Differences in breast cancer incidence among young women aged 20–49 years by stage and tumor characteristics, age, race, and ethnicity, 2004–2013

Meredith L. Shoemaker, Mary C. White, Manxia Wu, Hannah K. Weir, Isabelle Romieu

15.02.2018 | Epidemiology | Ausgabe 3/2018

Lipid-lowering drugs, dyslipidemia, and breast cancer risk in a Medicare population

Catherine Schairer, D. Michal Freedman, Shahinaz M. Gadalla, Ruth M. Pfeiffer

19.02.2018 | Epidemiology | Ausgabe 3/2018

Factors associated with improved outcomes for metastatic inflammatory breast cancer patients

Anna Weiss, Rhiana S. Menen, Heather Y. Lin, Yu Shen, Kelly J. Rosso, Simona Shaitelman, Wendy Woodward, Vicente Valero, Naoto T. Ueno, Isabelle Bedrosian, Gildy Babiera

10.02.2018 | Brief Report | Ausgabe 3/2018

MOBCdb: a comprehensive database integrating multi-omics data on breast cancer for precision medicine

Bingbing Xie, Zifeng Yuan, Yadong Yang, Zhidan Sun, Shuigeng Zhou, Xiangdong Fang

12.02.2018 | Letter to the Editor | Ausgabe 3/2018

Is invasion a necessary step for metastases in breast cancer? Narod SA, Sopik V

Alan B. Hollingsworth MD

14.03.2018 | Rebuttal Letter | Ausgabe 3/2018

Reply to Hollingsworth: does breast cancer metastasize in the clinical window between the mammogram and the mass?

Steven A. Narod

Aktuelle Ausgaben

Neu im Fachgebiet Onkologie

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update Onkologie und bleiben Sie gut informiert – ganz bequem per eMail.

Bildnachweise